1. Home
  2. OBAI vs BIVI Comparison

OBAI vs BIVI Comparison

Compare OBAI & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

N/A

Current Price

$0.34

Market Cap

9.4M

ML Signal

N/A

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$2.07

Market Cap

10.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBAI
BIVI
Founded
2017
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
10.3M
IPO Year
2025
2013

Fundamental Metrics

Financial Performance
Metric
OBAI
BIVI
Price
$0.34
$2.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.4M
10.9M
Earning Date
05-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
40.53
74.83
EPS
N/A
N/A
Revenue
$9,972,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.42
N/A
52 Week Low
$0.31
$0.82
52 Week High
$19.95
$3.79

Technical Indicators

Market Signals
Indicator
OBAI
BIVI
Relative Strength Index (RSI) 37.32 56.74
Support Level $0.31 $1.14
Resistance Level $0.48 $2.35
Average True Range (ATR) 0.04 0.31
MACD 0.01 0.02
Stochastic Oscillator 17.39 70.00

Price Performance

Historical Comparison
OBAI
BIVI

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: